BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1032573)

  • 1. [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
    Klein WW; Brandt D; Fluch N; Goebel R; Holzer H; Pöch G
    Adv Clin Pharmacol; 1976; 11():79-85. PubMed ID: 1032573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinical and hemodynamic investigations on two beta-receptor blocking agents (pindolol and mepindolol) in normal subjects.
    Wink K
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):126-30. PubMed ID: 6715080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proceedings: The effect of beta receptor treatment with pindolol on the plasma renin activity and the left-ventricular dynamics in essential hypertension].
    Nussberger J; Vetter W; Krayenbühl HP; Siegenthaler
    Schweiz Med Wochenschr; 1975 Nov; 105(44):1462-4. PubMed ID: 1215927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic and neurohumoral effects of pindolol: a beta-adrenoceptor antagonist with high intrinsic sympathomimetic activity in patients with dilated cardiomyopathy.
    Majid PA; Niznick J; Nishizaki S; Morris WM; Sole MJ
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):309-14. PubMed ID: 2444779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
    v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
    J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension.
    Omvik P; Lund-Johansen P; Haugland H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S182-4. PubMed ID: 2455128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
    Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1976; 199(4):251-5. PubMed ID: 1266662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol and renal hemodynamics at rest and during exercise.
    Malini PL; Strocchi E; Ambrosioni E
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):611-4. PubMed ID: 6668099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the treatment with propranolol and pindolol on selected hemodynamic parameters in patients with primary arterial hypertension].
    Trojnar R; Markiewicz M; Rymar B; Wysokiński A
    Wiad Lek; 1989 Aug 15-Sep 15; 42(16-18):929-34. PubMed ID: 2701039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
    Aoki K; Sato K
    Arzneimittelforschung; 1982; 32(9):1141-5. PubMed ID: 6756418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.